載入...
Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
Current Indian guidelines recommend twice-annual CD4 testing to monitor first-line antiretroviral therapy (ART), with a plasma HIV RNA test to confirm failure if CD4 declines, which would prompt a switch to second-line ART. We used a mathematical model to assess the clinical benefits and cost-effect...
Na minha lista:
| 發表在: | AIDS Res Hum Retroviruses |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Mary Ann Liebert, Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994680/ https://ncbi.nlm.nih.gov/pubmed/29620932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2017.0258 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|